RT Journal Article
SR Electronic
T1 High prevalence of mild asthma among asthmatics visiting emergency department (ED)
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP PA3713
DO 10.1183/13993003.congress-2021.PA3713
VO 58
IS suppl 65
A1 Zafeiria Barmparessou
A1 Aliki Korkontzelou
A1 Marios Ioannou
A1 Nikolaos Vichos
A1 Margarita Gkotsina
A1 Katerina Mprinia
A1 Vasiliki Saltagianni
A1 Timoleon Giannakas
A1 Vassilis Giannakoulis
A1 Nikolaos Athanasiou
A1 Archontoula Antonoglou
A1 Sophia Gida
A1 Sotiris Kakavas
A1 Georgios Boulbasakos
A1 Sofia Pappa
A1 Efthimios Zervas
A1 Paraskevi Katsaounou
YR 2021
UL http://erj.ersjournals.com/content/58/suppl_65/PA3713.abstract
AB Asthma exacerbations are a common cause of ED visits and can be life-threatening for patients with asthma. Identification of these patients characteristics could help improve their management and reduce exacerbations rate.We called for a 3-month follow-up visit patients that visited ED and were initially diagnosed with asthma exacerbation. Patients with a definite diagnosis of asthma were finally assessed in terms of the following parameters (Table 1a).100 patients were enrolled, with 34% being newly diagnosed with asthma. The majority of them had mild asthma, outreaching 72.6% in GINA stages I and II. 13.7% were classified in stage III and 13.7% in stages IV/V. Prior to ED visit treatment included ICS/LABA(32.3%), SABA as needed(24.2%), ICS/LABA plus LAMA(19.4%), ICS/LABA as needed(9.7%) and 8.1% did not receive any treatment. 62.3% were adherent at prescribed treatment. Active smoking was self-reported by 40.4% and passive smoking outreached 31% in non-smokers. Following HAD’s score evaluation 31.2% showed anxiety and 12.5% showed depression (cutoffs>11). See all characteristics on Table 1b.Conclusively, 1/3 of patients visiting ED with asthma exacerbation, were newly diagnosed with asthma. Most of patients were classified in stages I and II and a significant proportion used SABA monotherapy prior to visit. Smoking, poor adherence, psychopathology and commorbidities were highly prevalent characteristics among participants. FootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3713.This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).